Earlier this year, the Securities and Exchange Commission (the “SEC”) finalized amendments to its regulations to modernize and simplify disclosure requirements for public companies, investment advisors and investment companies, consistent with the Commission’s mandate under the Fixing America’s Surface Transportation (FAST) Act. The amendments are intended to improve the readability and navigability of disclosure documents and discourage repetition and disclosure of immaterial information.
The amendments included new procedures for filing redacted material agreements with the SEC without the need to make a formal confidential treatment request.
Companies may now file redacted material contracts without applying for confidential treatment so long as the redacted information (i) is not material and (ii) would be competitively harmful if publicly disclosed. This is the same standard as the prior confidential treatment requirements.
To file redacted material contracts, companies must:
The SEC will review these filings for compliance with the new rules and may requests supplemental information in connection with this review.
Shortly following the release of the finalized amendments, the SEC’s Division of Corporation Finance announced a streamlined procedure to extend confidential treatment for exhibits that are subject to a previously granted confidential treatment request.
The SEC Staff has developed a short form application to facilitate the process of filing an application to extend the time for which confidential treatment has been granted.
In this one-page document, companies must:
Companies are not required to refile the unredacted documents with the request or provide the supporting analysis previously provided if the analysis remains the same as presented in the most recent application.
The short form application is to be submitted by email to CTExtensions@sec.gov. If the SEC Staff has questions relating to the application, they will contact the company.
Please reach out to one or more of the authors of this alert if you would like more information regarding the changes being implemented by the amendments.
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.